Literature DB >> 26671038

Selection of Lymph Node-Positive Cases Based on Perirectal and Lateral Pelvic Lymph Nodes Using Magnetic Resonance Imaging: Study of the Japanese Society for Cancer of the Colon and Rectum.

Shimpei Ogawa1, Jin-Ichi Hida2, Hideyuki Ike3, Tetsushi Kinugasa4, Mitsuyoshi Ota5, Eiji Shinto6, Michio Itabashi7, Shingo Kameoka7, Kenichi Sugihara8.   

Abstract

PURPOSE: To investigate the optimum cutoff for lymph node size to identify cases positive for perirectal lymph node (PRLN) and lateral lymph node (LPLN) metastasis of lower rectal cancer on magnetic resonance imaging (MRI).
METHODS: The subjects were 449 patients who underwent preoperative MRI. Mesorectal excision was performed in all patients (combined with lateral pelvic lymph node [LN] dissection in 324) between 2004 and 2013 at 6 institutes. Cases were classified as cN positive and cN negative on the basis of the short axis of the largest LN being greater than or equal to a cutoff or less than a cutoff, respectively. PRLN and LPLN diagnoses using 5 and 10 mm cutoffs were compared with histologic diagnoses. Of the 449 patients, 55 received preoperative chemoradiotherapy. MRI was only performed after this therapy in all of these patients.
RESULTS: For PRLNs, 5 and 10 mm cutoffs gave area under the curve (AUC) values of 0.6364 and 0.5794, respectively. The 5 mm cutoff gave a significantly higher AUC value (P = 0.0152), with an accuracy of 63.7 %, sensitivity of 72.6 %, and specificity of 54.7 %. For right LPLNs, the respective AUC values were 0.7418 and 0.6326 (P = 0.0034), and the variables (5 mm cutoff) were 77.6, 68.6, and 79.7 %. For left LPLNs, AUC values were 0.7593 and 0.6559, respectively (P = 0.0057), and the variables (5 mm cutoff) were 79.3, 70.8, and 81.0 %.
CONCLUSIONS: Identification of LN-positive cases on the basis of PRLN and LPLN sizes was superior at a short-axis 5 mm cutoff. Size-based diagnosis of LN metastasis is simple and useful, but further investigation is needed to clarify whether it is superior to diagnosis based on morphology, such as shape, border, and signal intensity.

Entities:  

Mesh:

Year:  2015        PMID: 26671038     DOI: 10.1245/s10434-015-5021-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  23 in total

1.  The effect of formalin fixation on the size of pelvic sidewall lymph nodes.

Authors:  Kazushige Kawai; Teppei Morikawa
Journal:  Int J Colorectal Dis       Date:  2018-06-21       Impact factor: 2.571

Review 2.  Lateral Pelvic Lymph Node Metastases in Rectal Cancer: A Systematic Review.

Authors:  Y Atef; T W Koedam; S E van Oostendorp; H J Bonjer; A R Wijsmuller; J B Tuynman
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

3.  The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum.

Authors:  Shimpei Ogawa; Jin-Ichi Hida; Hideyuki Ike; Tetsushi Kinugasa; Mitsuyoshi Ota; Eiji Shinto; Michio Itabashi; Takahiro Okamoto; Kenichi Sugihara
Journal:  Int J Colorectal Dis       Date:  2016-08-30       Impact factor: 2.571

4.  Prediction of lateral pelvic lymph node metastasis from lower rectal cancer using magnetic resonance imaging and risk factors for metastasis: Multicenter study of the Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum.

Authors:  Shimpei Ogawa; Jin-Ichi Hida; Hideyuki Ike; Tetsushi Kinugasa; Mitsuyoshi Ota; Eiji Shinto; Michio Itabashi; Takahiro Okamoto; Masakazu Yamamoto; Kenichi Sugihara; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2017-07-31       Impact factor: 2.571

5.  Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.

Authors:  Yuki Sekido; Junichi Nishimura; Shiki Fujino; Takayuki Ogino; Norikatsu Miyoshi; Hidekazu Takahashi; Mamoru Uemura; Naotsugu Haraguchi; Taishi Hata; Chu Matsuda; Tsunekazu Mizushima; Kohei Murata; Junichi Hasegawa; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2019-10-08       Impact factor: 2.549

6.  Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.

Authors:  Takehito Yamamoto; Kenji Kawada; Koya Hida; Riki Ganeko; Susumu Inamoto; Mami Yoshitomi; Takeshi Watanabe; Yoshiharu Sakai
Journal:  Int J Clin Oncol       Date:  2019-02-05       Impact factor: 3.402

7.  Feasibility of Neoadjuvant FOLFOX Therapy Without Radiotherapy for Baseline Resectable Rectal Cancer.

Authors:  Michihiro Koizumi; Takeshi Yamada; Seiichi Shinji; Yasuyuki Yokoyama; Goro Takahashi; Takuma Iwai; Kohki Takeda; Keisuke Hara; Keiichiro Ohta; Eiji Uchida; Hiroshi Yoshida
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

8.  Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer.

Authors:  Yusuke Yamaoka; Yusuke Kinugasa; Akio Shiomi; Tomohiro Yamaguchi; Hiroyasu Kagawa; Yushi Yamakawa; Masakatsu Numata; Akinobu Furutani
Journal:  Int J Colorectal Dis       Date:  2017-07-31       Impact factor: 2.571

Review 9.  Diagnostic and management strategies for lateral pelvic lymph nodes in low rectal cancer-a review of the evidence.

Authors:  Dedrick Kok Hong Chan; Ker-Kan Tan; Takashi Akiyoshi
Journal:  J Gastrointest Oncol       Date:  2019-12

10.  Effective dissection for rectal cancer with lateral lymph node metastasis based on prognostic factors and recurrence type.

Authors:  Hajime Morohashi; Yoshiyuki Sakamoto; Takuya Miura; Daichi Ichinohe; Kotaro Umemura; Takanobu Akaishi; Kentaro Sato; Daisuke Kuwata; Keisuke Yamazaki; Taiichi Wakiya; Kenichi Hakamada
Journal:  Int J Colorectal Dis       Date:  2021-02-01       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.